Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Adam Logal Insider Profile
4 Followers
Adam Logal, Sr. VP, CFO at Opko Health, holds 179.16K shares in Opko Health (Ticker: OPK), holds ― shares in Xenetic Biosciences (Ticker: XBIO), holds 9.57K shares in Vaxart (Ticker: VXRT). Most recently, Adam Logal Bought ― shares of Opko Health on May 10, 2019 for an estimated value of 6.63K.
Profitable Transactions
0 out of 4 Profitable Transactions
Average Return
-14.80%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Adam Logal holds in companies
Most Profitable Insider Trade
The most profitable trade made by Adam Logal
Adam Logal's Trading History
Opko Health
May 10, 2019
Sr. VP, CFO
Informative Buy
6.63K
$241.87K
Xenetic Biosciences
―
Director
―
―
Vaxart
―
Interim CFO, CAO and Treasurer
―
$9.03K
List of latest transactions for each holding click on a transaction to see Adam Logal's performance on stock
You May Also Like
Adam Logal insider profile FAQ
What is the percentage of profitable transactions made by Adam Logal?
The percentage of profitable transactions made by Adam Logal is 0%.
What is the average return per transaction made by Adam Logal?
The average return per transaction made by Adam Logal is -14.80%.
What stocks does Adam Logal hold?
Adam Logal holds: OPK, XBIO, VXRT stocks.
What was Adam Logal’s latest transaction?
Adam Logal latest transaction was an Informative Buy of $6.63K.
What was Adam Logal's most profitable transaction?
Adam Logal’s most profitable transaction was an Informative Buy of OPK stock on May 10, 2019. The return on the trade was -0.90%.
What is Adam Logal's role in Opko Health?
Adam Logal's role in Opko Health is Sr. VP, CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.